All ETDs from UAB

Advisory Committee Chair

Gail Johnson-Voll

Advisory Committee Members

Etty Benveniste

Stuart Frank

Mathieu Lesort

Joanne Murphy-Ullrich

Document Type

Dissertation

Date of Award

2010

Degree Name by School

Doctor of Philosophy (PhD) Heersink School of Medicine

Abstract

Low density Lipoprotein receptor Related 6 (LRP6) functions as an essential co-receptor for Wnt/Beat;-catenin signaling as pathway activation, reflected by cytosolic Beta-catenin stabilization and TCF/LEF-1 transactivation, requires Glycogen Synthase Kinase 3Beta(GSK3Beta)-mediated phosphorylation of multiple PPP(S/T)P motifs within the membrane anchored LRP6 intracellular domain. Additionally, LRP6 undergoes a proteolytic cleavage event resulting in the formation of a soluble LRP6 intracellular domain (LRP6-ICD). LRP6-ICD can function within the Wnt/Beta-catenin pathway by interacting with GSK3Beta and attenuating the phosphorylation of GSK3Beta substrates such as cytosolic Beta-catenin as well as stimulate TCF/LEF-1 activity. However, LRP6-ICD's role(s) within the Wnt/Beta-catenin pathway and the mechanism(s) that govern LRP6-ICD activity are not clear. The cytosolic function of LRP6-ICD has been examined, but its possible function in the nucleus remains unexplored. A better understanding of LRP6-ICD biology will improve our understanding of the regulation of the Wnt/Beta-catenin pathway. The objective for the first part of the project was to determine if LRP6-ICD requires GSK3Beta-mediated phosphorylation of its PPP(S/T)P motifs to function within the Wnt/Beta-catenin pathway, similar to LRP6. Results show LRP6-ICD is functionally distinct from LRP6 as LRP6-ICD functions within the pathway in the absence of PPP(S/T)P phosphorylation and functions as a pathway modulatory protein not as a primary activating component. We also showed LRP6-ICD modulates the pathway by functioning as a true GSK3Beta effector protein capable of directly attenuating GSK3Beta kinase activity. In the second part, we analyzed a potential role for LRP6-ICD in the nucleus. Our findings showed LRP6-ICD is a nucleocytoplasmic protein that differentially regulates Wnt/Beta-catenin pathway activity depending upon its localization and protein-protein interaction. We validated the hypothesis that cytosolic LRP6-ICD positively modulates Wnt/Beta-catenin activity through GSK3Beta and enhanced cytosolic Beta-catenin stabilization. Surprisingly, nuclear LRP6-ICD negatively modulates the pathway by interacting with and attenuating Amino-terminal Enhancer of Split (AES), a positive Wnt/Beta-catenin modulatory protein. To summarize, our studies reveal that LRP6-ICD differentially modulates the Wnt/Beta-catenin pathway in a context and localization dependent manner. Our studies also provide further insight concerning the growing role modulatory proteins play in the Wnt/Beta-catenin pathway and mechanistic diversity of the pathway.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.